Getting to the Sweet Spot: The Emerging Use of Once-Weekly Basal Insulin Therapies in Type 2 Diabetes

Insulin is a mainstay in type 1 diabetes (T1D) and due to the progressive nature of type 2 diabetes (T2D), insulin is commonly required. However, insulin can involve complex regimens and a high burden of injections and monitoring, which can lead to patient non-adherence and non-persistence. Additionally, clinical inertia can serve as a barrier to initiating, intensifying, and titrating basal insulin therapy, leading to suboptimal glucose management and an increased risk for diabetes-related morbidity and mortality.

Once-weekly basal insulin therapies may provide a patient-centered treatment to overcome these barriers, ideally improving adherence, persistence, patient satisfaction, quality of life, and patient outcomes. Pharmacists can play an important role in understanding the current clinical evidence and ensuring these agents are appropriately used once they become available. This activity will discuss the most recent clinical evidence surrounding once-weekly basal insulin therapies, their potential role in helping overcome clinical inertia, the differences between once-daily and once-weekly basal insulins, and opportunities to dispel misconceptions related to these emerging therapies. Additionally, this webinar will include interactive case presentations throughout the activity.


Tuesday, June 30
3 – 4 p.m. ET


Webinar Registration
Registration is required for this webinar.

Speakers


Susan Cornell

Susan Cornell, PharmD, CDCES, FAPhA, FADCES, Activity Chair
Experiential Education Specialist, Adjunct Professor – Midwestern University College of Pharmacy
Diabetes Care and Education Specialist and Consultant – Bolingbrook Christian Health Clinic – Bolingbrook, IL, Will-Grundy Medical Clinic – Joliet, IL
Downers Grove, Illinois

Susan Cornell is an Experiential Education Specialist and Professor Emeritus at Midwestern University College of Pharmacy in Downers Grove, Illinois. Dr. Cornell is also a clinical pharmacist, consultant and certified diabetes care and education specialist. Her current clinical practice is with the Bolingbrook Christian Health Center and the Will-Grundy Medical Clinic, where she supervises student pharmacists, as they provide medication therapy management and diabetes care and education for underserved populations. Dr. Cornell served as President of the Illinois Pharmacists Association in 2011. She has received numerous awards and recognitions, including the 2024 APhA-ASP Outstanding Chapter Advisor Award, 2022 ADCES Allene Von Son Distinguished Serves Award, the 2021, 2019 and 2011 MWU Outstanding Faculty Advisor, 2017 ADCES Outstanding Illinois Diabetes Educator of the Year, and the 2014 Bowl of Hygeia, to list a few. She is an active member of the American Diabetes Association. She is also actively involved with the Association of Diabetes Care and Education Specialists, where she previously served on their board of directors and continues to assist on various committees. Dr. Cornell has been invited to give numerous presentations to various healthcare professionals and community groups worldwide. She has served as editor, as well as, published and contributed to many peer-reviewed, professional written and online publications. Dr. Cornell is the associate editor of the ADCES Art and Science of Diabetes Care and Education Desk Reference- 3rd thru 6th edition.



Jennifer Trujillo

Jennifer Trujillo, PharmD, BCPS, BC-ADM, CDCES, FCCP
Professor
University of Colorado Skaggs School of Pharmacy
Aurora, Colorado

Jennifer Trujillo is a Professor at the University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences in Aurora, Colorado. She practices as a clinical pharmacist and certified diabetes care and education specialist at the University of Colorado Diabetes and Endocrinology Clinic. Her clinical and scholarly interests focus on optimizing diabetes treatment strategies and improving patient access to medications and technology. She teaches diabetes pharmacotherapy and advanced diabetes management in the Doctor of Pharmacy program and is deeply passionate about educating future health care professionals on the power of collaboration, empathy, shared decision-making, and a person-centered approach to diabetes care.



Target Audience

This activity was planned to meet the educational needs of pharmacists managing patients with type 2 diabetes.


Learning Objectives

  • Identify factors leading to clinical inertia for patients with type 2 diabetes who require basal insulin therapy.
  • Analyze current clinical evidence regarding the safety and efficacy of emerging once-weekly basal insulin therapies.
  • Apply current clinical evidence ensuring optimal use and addressing any patient concerns related to once-weekly basal insulin therapies.

Agenda

  • 3 p.m. – Welcome and Introductions
    Susan Cornell
  • 3:05 p.m. – Overcoming Clinical Inertia and Engaging in Shared Decision Making for Patients Requiring Insulin Therapy
    Susan Cornell
  • 3:20 p.m. – Current Clinical Evidence of Emerging Once-Weekly Basal Insulin Therapies
    Jennifer Trujillo
  • 3:35 p.m. – Dispelling Misconceptions and Addressing Nuances of Once-Weekly Basal Insulin Therapies
    All Faculty
  • 3:55 p.m. – Faculty Discussion, Questions and Answers
    All Faculty

Accredited for CPE

ACPE #: 0204-0000-26-410-L01-P
CE Credit: 1.0 contact hour (0.1 CEU)
Activity Type: Application-based
Activity Fee: No charge

To Claim CE for the webinar, enter the CE code announced during the activity and complete the evaluation.

 


 

ACPE logo black and white The American Society of Health-System Pharmacists is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education with Commendation.
ASHP Advantage logo Provided by ASHP.
Supported by an educational grant from Lilly.
For questions and assistance to participate, contact us.